Is CRM a buy, hold, or sell?
CRM carries a valuation grade of Strong Buy. At a trailing P/E of 17.6, the stock trades at a 45% discount to the Technology sector median of 32.0x. Our discounted cash flow model produces an intrinsic range of $173–$475 — implying a +113% margin of safety at the current price of $151.78. The width of the DCF range reflects genuine uncertainty in the terminal growth rate assumption: the correct framework is a probability-weighted distribution over scenarios, not a single point estimate. See the DCF valuation framework for full methodology.
With a 12% beat rate on recent quarters, earnings predictability has been mixed. The most recent quarter delivered a 24.1% earnings surprise. Analyst estimate revisions are trending upward.
What are CRM's key risk factors?
With a beta of 1.15, CRM exhibits an above-market risk profile relative to the broad market. The 95th-percentile CVaR of -27.9% on a one-month horizon should inform position sizing directly: at a 10% portfolio weight, this tail event contributes approximately 2.8% of total portfolio loss in the worst 5% of months. Net margins stand at 18.7%. Return on equity of 16.9% suggests solid capital efficiency. Leverage is moderate with debt-to-equity at 124%.
At 0.74, the put/call ratio skews bullish, with call buyers dominating recent flow. Implied volatility of 42.9% is below realized volatility of 56.8%, potentially making options relatively cheap. Insider transactions show net buying of $9.1M over the trailing period, a signal often associated with management confidence. Short interest stands at 8.6% of float, a moderate level.
How does CRM fit in a diversified portfolio?
At typical HENRY portfolio weights — 10–20% of the equity allocation — CRM carries a beta of 1.15, meaning it amplifies broad market moves proportionally. The appropriate weight is not a function of conviction alone, but of the full covariance structure across all holdings. See the Ledoit-Wolf covariance framework for the methodology behind these calculations.
Among closely correlated names, CRM shows the strongest co-movement with NOW (0.78), WDAY (0.75), SAP (0.59). Investors seeking diversification should note these correlation dynamics when constructing multi-asset portfolios. With the top peer correlation at 0.78, adding CRM to a portfolio that already holds these names provides limited marginal diversification benefit — particularly during stress events when correlations converge toward 1.0.
True portfolio risk is a function of the full covariance structure across all holdings — not individual stock metrics. The Portfolio Health Check quantifies this at the portfolio level: it surfaces hidden concentration, marginal CVaR contributions, and the degree to which your overall allocation deviates from an optimal risk-adjusted mandate. The CRM analysis here is a single node in that larger structure.
For analysis of the structural AI infrastructure capex cycle driving demand for CRM — see our thematic deep-dive: The $7 Trillion Race: AI Infrastructure as a Decade-Long Investment Cycle.
